キッズウェル・バイオ(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|
| 東証GRT | 医薬品 | 4584/ - | - |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|
| 2017/06/09 | 日証協 | 199,994株 | +1.11% | 7,188株 | +89.16% | 350,679株 | +1.21% | 11,700株 | +101.72% |
| 2017/06/02 | 日証協 | 197,794株 | +0.61% | 3,800株 | -59.95% | 346,479株 | +40.57% | 5,800株 | -94.4% |
| 2017/05/26 | 日証協 | 196,594株 | +0.15% | 9,488株 | -56.07% | 246,479株 | +0.57% | 103,500株 | +1076.14% |
| 2017/05/19 | 日証協 | 196,294株 | +0.77% | 21,600株 | +208.57% | 245,079株 | +1.16% | 8,800株 | +104.65% |
| 2017/05/12 | 日証協 | 194,794株 | +2.85% | 7,000株 | +37.25% | 242,279株 | +2.45% | 4,300株 | +19.44% |
| 2017/05/02 | 日証協 | 189,394株 | +1.5% | 5,100株 | -76.82% | 236,479株 | +0.68% | 3,600株 | -40% |
| 2017/04/28 | 日証協 | 186,594株 | +11.74% | 22,000株 | -43.87% | 234,879株 | +10.23% | 6,000株 | -71.7% |
| 2017/04/21 | 日証協 | 166,994株 | -8.8% | 39,194株 | -23.75% | 213,079株 | -8.19% | 21,200株 | -46.49% |
| 2017/04/14 | 日証協 | 183,100株 | +24.47% | 51,400株 | +50.73% | 232,079株 | +18.79% | 39,618株 | -5.67% |
| 2017/04/07 | 日証協 | 147,100株 | -4.97% | 34,100株 | +218.87% | 195,367株 | -0.25% | 42,000株 | +246.53% |
| 2017/03/31 | 日証協 | 154,794株 | +0.91% | 10,694株 | +4.84% | 195,853株 | -34.36% | 12,120株 | +423.77% |
| 2017/03/24 | 日証協 | 153,400株 | +4.07% | 10,200株 | -88.96% | 298,383株 | -11.66% | 2,314株 | -96.04% |
| 2017/03/17 | 日証協 | 147,400株 | +146.9% | 92,394株 | +717.65% | 337,783株 | +19.87% | 58,400株 | +394.92% |
| 2017/03/10 | 日証協 | 59,700株 | -25.28% | 11,300株 | 0% | 281,783株 | -7.12% | 11,800株 | -89.59% |
| 2017/03/03 | 日証協 | 79,900株 | 0% | 0株 | 0% | 303,383株 | +80.2% | 113,400株 | +432.39% |
| 2017/02/24 | 日証協 | 79,900株 | -0.06% | 0株 | -100% | 168,363株 | -2.88% | 21,300株 | +162.96% |
| 2017/02/17 | 日証協 | 79,944株 | +4.03% | 3,100株 | +121.43% | 173,363株 | +1.83% | 8,100株 | +72.05% |
| 2017/02/10 | 日証協 | 76,844株 | +0.39% | 1,400株 | -70.83% | 170,255株 | +1.61% | 4,708株 | -38.05% |
| 2017/02/03 | 日証協 | 76,544株 | -1.67% | 4,800株 | 0% | 167,555株 | -36.21% | 7,600株 | +26.54% |
※株式分割は考慮していませんのでご注意ください。
Page Top